Grassley Probes Two Drugmakers Over 340B Pricing Program

esilverman written two drugmakers and demanded they explain why they refused to provide required discounts to an Iowa hospital. The Iowa Republican took this move after confirming ...

Opposing sides bring in big lobbying guns in showdown over regulating compounders

Eric Palmer In the first 6 months of this year, the International Academy of Compounding Pharmacists, an advocacy group tied to the compounding industry, shelled out nearly $ 440,000 ...

What’s In A Name? The Fight Over Biosimilar Nomenclatures

esilverman More than a year after drugmakers began jousting over names for biosimilars, the trade group for generic drugmakers has taken the formal step of filing a citizen’s ...

Health Spending Over The Coming Decade Expected To Exceed Economic Growth

barbara.lempert By Jordan Rau Kaiser Health News Staff Writer Sep 18, 2013 The nation’s total health spending will bump up next year as the health law expands insurance coverage ...

Congressman rails at Pfizer over problems with sarin gas antidote

Eric Palmer Pfizer's Meridian unit that makes the injector "has received millions of taxpayer dollars for doses of this drug, some of which do not meet specifications," ...

J&J trying to drag Boehringer into arbitration over Doxil production lapses

Eric Palmer Many drugmakers had supplies interrupted when Boehringer Ingelheim closed its Bedford, OH plant in 2011 because of serious quality issues, but it was a shortage of Johnson ...

UPDATED: Merck demand triggers expanding patent war with Gilead over sofosbuvir

John Carroll Gilead is rolling out its big legal guns to defend its control of the experimental hepatitis C drug sofosbuvir, one of the most valuable therapies in the industry's ...

M&A watch: Amgen and Onyx haggle over Kyprolis data in stalled buyout talks

Ryan McBride As sources tell Bloomberg, the companies have been stalled in their talks over Amgen's proposed $ 130-per-share acquisition of Onyx because Amgen wants data from an ...

AIDS Group Wins Legal Battle With FDA Over Confidential Data

esilverman Over the past three years, the AIDS Healthcare Foundation waged a losing battle against Truvada, which is sold by Gilead Sciences, for AIDS prevention. The Los Angeles-based ...

China Revokes Patent On Gilead AIDS Drug Over Pricing

esilverman In the latest row between global drugmakers and governments over affordable medicines, China’s State Intellectual Property Office revoked the patent on Viread, ...

Congress Must Clarify FDA Authority Over Compounders: GAO

esilverman As Congress gears up to consider controversial legislation for overseeing compounding pharmacies, a new report from the Government Accountability Office largely ...

PhRMA, A Congresswoman And A Flap Over Campaign Finance Rules

esilverman Did a congresswoman violate campaign laws by enlisting campaign help from PhRMA? That question is being asked after a senior aide to Colleen Hanabusa, a Democrat ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS